Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J; Triptan Cardiovascular Safety Expert Panel.
Dodick D, et al. Among authors: smith tr.
Headache. 2004 May;44(5):414-25. doi: 10.1111/j.1526-4610.2004.04078.x.
Headache. 2004.
PMID: 15147249
Review.